Asymmetric dimethylarginine in cerebral small vessel disease

Stroke

Volumn 38, Issue 2, 2007, Pages 411-413

  Khan, Usman ^a   Hassan, Ahamad ^a   Vallance, Patrick ^a   Markus, Hugh S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

ADMA; Endothelial dysfunction; Homocysteine; Lacunar; Leukoaraiosis; Stroke

Indexed keywords

HOMOCYSTEINE; N(G),N(G) DIMETHYLARGININE;

AGED; ARTICLE; BRAIN CAPILLARY; BRAIN INFARCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; LEUKOARAIOSIS; MALE; MICROANGIOPATHY; PRIORITY JOURNAL; RISK FACTOR;

AGED; ARGININE; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; LEUKOARAIOSIS; MALE; MICROCIRCULATION; MIDDLE AGED;

EID: 33846601836     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254500.27412.ac     Document Type: Article

References (7)

1. Hassan A, Hunt BJ, O'Sullivan M, Parmar K, Bamford JM, Briley D, Brown MM, Thomas DJ, Markus HS. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoariosis. Brain. 2003;126:424-432.
2. Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain. 2004;127:212-219.
3. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572-575.
4. Zoccali C. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move. J Hypertens. 2006;24:611-619.
5. Lentz SR, Rodionov RN, Dayal S. Hyperhomocystinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA. Atheroscler Suppl. 2003;4:61-65.
6. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
7. Furuki K, Adachi H, Matsuoka H, Enomoto M, Satoh A, Hino A, Hirai Y, Imaizumi T. Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery. An epidemiological study. Atherosclerosis 2006;Epub.